Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Mark C. Mckenna currently holds 15,300 shares of Spyre Therapeutics, Inc. (SYRE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mark C. Mckenna has been a net seller of SYRE stock. They have purchased $0 and sold $15.2M worth of shares.
Mark C. Mckenna's most recent insider trade was on Jan 7, 2026, when they sold 15,300 shares at $0.00 per share.
Mark C. Mckenna serves as Executive at Spyre Therapeutics, Inc. (SYRE). They have executed 31 insider transactions totaling $15.2M over their tenure at the company.
Mark C. Mckenna holds the position of Executive at Spyre Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 7 years and currently hold a stake valued at $0.
Mark C. Mckenna has shown a selling trading pattern, with $0 in total purchases and $15.2M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Mark C. Mckenna was on Feb 16, 2023, when they sold $3.0M worth of RXDX shares. This transaction involved 25,000 shares at $119.87 per share.
Mark C. Mckenna currently owns 15,300 shares of Spyre Therapeutics, Inc. (SYRE), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Mark C. Mckenna's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Mark C. Mckenna has 31 Form 4 filings on record as an insider at Spyre Therapeutics, Inc..
Set alerts for Mark C. Mckenna and 40,000+ other insiders.